CORRECTING and REPLACING -- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Obagi Medical Products, Inc. in Connection With the Sale of the Company to Valea

Wed Apr 3, 2013 2:51pm EDT

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130403:nGNXUXMGQa

NEW YORK, April 3, 2013 (GLOBE NEWSWIRE) -- In a press release issued today by Levi & Korsinsky
with the same headline, please note that the per share amount in the third paragraph should be
$24.00, not $19.75 as originally stated. The corrected release follows:

Levi & Korsinsky notifies investors of Obagi Medical Products, Inc. ("Obagi" or the "Company")
(Nasdaq:OMPI) of claims of breaches of fiduciary duty and other violations of state law against
the board of directors of the Company in connection with the sale of the Company to Valeant
Pharmaceuticals International, Inc. (NYSE:VRX). A complaint was filed in Delaware state court.

Click here to learn how to join the action: http://zlk.9nl.com/obagi-medical-products-ompi/
http://www.globenewswire.com/newsroom/ctr?d=10027307&l=3&u=http%3A%2F%2Fzlk.9nl.com%2Fobagi-medical-products-ompi%2F
, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Obagi shareholders will receive $24.00 for each share of Obagi
common stock they own. The claims concern whether the Obagi Board of Directors breached their
fiduciary duties to stockholders by failing to adequately shop the Company before entering into
this transaction and whether Valeant Pharmaceuticals International, Inc. is underpaying for Obagi
shares, thus unlawfully harming Obagi stockholders.

If you own common stock in Obagi and wish to obtain additional information, please contact Joseph
E. Levi, Esq. either via email at jlevi@zlk.com
http://www.globenewswire.com/newsroom/ctr?d=10027307&l=5&a=jlevi%40zlk.com&u=mailto%3Ajlevi%40zlk.com
 or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or
http://zlk.9nl.com/obagi-medical-products-ompi/
http://www.globenewswire.com/newsroom/ctr?d=10027307&l=5&u=http%3A%2F%2Fzlk.9nl.com%2Fobagi-medical-products-ompi%2F
.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The
firm has extensive expertise in prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and shareholder lawsuits.  The
attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to
serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully
recovered multimillion-dollar damages awards on behalf of investors.  For more information, please
feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not
guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP
         Joseph Levi, Esq.
         Eduard Korsinsky, Esq.
         30 Broad Street - 24th Floor
         New York, NY 10004
         Tel: (212) 363-7500
         Toll Free:  (877) 363-5972
         Fax: (866) 367-6510
         www.zlk.com